These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 27032075

  • 1. Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.
    van Twist DJ, Houben AJ, de Haan MW, de Leeuw PW, Kroon AA.
    J Hypertens; 2016 Jun; 34(6):1160-9. PubMed ID: 27032075
    [Abstract] [Full Text] [Related]

  • 2. Differences in renal hemodynamics and renin secretion between patients with unifocal and multifocal fibromuscular dysplasia.
    van Twist DJL, de Heer PWM, Houben AJHM, de Haan MW, de Leeuw PW, Kroon AA.
    J Hypertens; 2018 Aug; 36(8):1729-1735. PubMed ID: 29889158
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
    Palm F, Connors SG, Mendonca M, Welch WJ, Wilcox CS.
    Hypertension; 2008 Feb; 51(2):345-51. PubMed ID: 18158356
    [Abstract] [Full Text] [Related]

  • 6. Acute eprosartan-induced intrarenal vasodilation in hypertensive humans is not influenced by dietary sodium intake or angiotensin II co-infusion.
    van Twist DJ, Houben AJ, de Leeuw PW, Kroon AA.
    J Hypertens; 2016 Aug; 34(8):1607-14. PubMed ID: 27214088
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.
    van Twist DJ, Houben AJ, de Haan MW, Mostard GJ, Kroon AA, de Leeuw PW.
    Hypertension; 2013 Oct; 62(4):789-93. PubMed ID: 23918750
    [Abstract] [Full Text] [Related]

  • 8. Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA-POL study.
    Januszewicz M, Januszewicz A, Michałowska I, Klisiewicz A, Dobrowolski P, Warchoł-Celińska E, Jóźwik-Plebanek K, Witkowski A, Kądziela J, Kowalczyk K, Ziębka J, Talarowska P, Kabat M, Florczak E, Pręgowska-Chwała B, Tykarski A, Stryczyński Ł, Stefańczyk L, Litwin M, Widecka K, Adamczak M, Szczerbo-Trojanowska M, Hoffman P, Więcek A, Prejbisz A.
    Pol Arch Intern Med; 2019 Apr 30; 129(4):234-241. PubMed ID: 31038477
    [Abstract] [Full Text] [Related]

  • 9. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM.
    Am J Med; 1984 May 31; 76(5B):29-37. PubMed ID: 6328984
    [Abstract] [Full Text] [Related]

  • 10. Renal artery fibromuscular dysplasia and its effect on the kidney.
    van Twist DJL, de Leeuw PW, Kroon AA.
    Hypertens Res; 2018 Sep 31; 41(9):639-648. PubMed ID: 29968847
    [Abstract] [Full Text] [Related]

  • 11. Preoperative diagnosis of renovascular hypertension. The use of acute stimulation of renin secretion.
    Delin K, Aurell M, Granerus G.
    Acta Med Scand; 1984 Sep 31; 215(4):363-9. PubMed ID: 6375275
    [Abstract] [Full Text] [Related]

  • 12. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK.
    Am J Med; 1984 May 31; 76(5B):22-8. PubMed ID: 6328983
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
    Hartono SP, Knudsen BE, Lerman LO, Textor SC, Grande JP.
    BMC Nephrol; 2014 Apr 04; 15():58. PubMed ID: 24708836
    [Abstract] [Full Text] [Related]

  • 15. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia.
    Bofinger A, Hawley C, Fisher P, Daunt N, Stowasser M, Gordon R.
    J Hum Hypertens; 2001 Mar 04; 15(3):185-90. PubMed ID: 11317203
    [Abstract] [Full Text] [Related]

  • 16. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H, Palmgren E, Widgren B, Aurell M.
    Clin Sci (Lond); 2005 Sep 04; 109(3):311-7. PubMed ID: 15901242
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A, Pelà G, Musiari L, Crocamo A, Boeti L, Cabassi A, Biggi A, Cherney DZ.
    Am J Physiol Renal Physiol; 2013 Jul 01; 305(1):F42-51. PubMed ID: 23657857
    [Abstract] [Full Text] [Related]

  • 18. High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.
    Merla S, Simoni R, Tedeschi S, Ferrari M, Passeri G, Marcato C, Epifani E, Semproni I, Zini G, Verzicco I, Coghi P, Volpi R, Cabassi A.
    Acta Biomed; 2021 Apr 30; 92(S1):e2021162. PubMed ID: 33944843
    [Abstract] [Full Text] [Related]

  • 19. Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis.
    Webb DJ, Cumming AM, Adams FC, Hodsman GP, Leckie BJ, Lever AF, Morton JJ, Murray GD, Robertson JI.
    J Hypertens; 1984 Dec 30; 2(6):605-14. PubMed ID: 6396332
    [Abstract] [Full Text] [Related]

  • 20. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY, Campbell JE, Stone PA, Broce M, Bates MC, AbuRahma AF.
    J Vasc Surg; 2012 Feb 30; 55(2):421-7. PubMed ID: 22112553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.